These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28294731)

  • 1. [Platelet Activity in Patients With Third Degree Arterial Hypertension and Metabolic Syndrome].
    Medvedev IN; Zavalishina SY
    Kardiologiia; 2016 Jan; 56(1):48-0. PubMed ID: 28294731
    [No Abstract]   [Full Text] [Related]  

  • 2. Parameters of high-density lipoproteins in patients with arterial hypertension in combination with other components of metabolic syndrome.
    Ozerova IN; Perova NV; Shchel'tsyna NV; Mamedov MN
    Bull Exp Biol Med; 2007 Mar; 143(3):320-2. PubMed ID: 18225752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of lisinopril on platelet aggregation in patients with arterial hypertension with metabolic syndrome].
    Medvedev IN; Gromnatskiĭ NI; Golikov BM; Al'-Zuraĭki EM; Li VIu
    Kardiologiia; 2004; 44(10):57-9. PubMed ID: 15477792
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men.
    Ueba T; Nomura S; Inami N; Nishikawa T; Kajiwara M; Iwata R; Yamashita K
    J Atheroscler Thromb; 2010 Apr; 17(4):342-9. PubMed ID: 20379056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hypertension in the metabolic syndrome: who is affected?
    Velarde G; Berk BC
    Curr Hypertens Rep; 2005 Dec; 7(6):418-26. PubMed ID: 16386197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of therapy with diuretics on the functional activity of platelets in patients with arterial hypertension and abdominal obesity].
    Simonenko VB; Medvedev IN; Briukhovetskiĭ AG
    Klin Med (Mosk); 2012; 90(11):54-6. PubMed ID: 23516856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of lovastatin on adhesive and aggregation function of platelets in patients with arterial hypertension and dislipidemia].
    Medvedev IN; Skoriatina IA
    Klin Med (Mosk); 2010; 88(2):38-40. PubMed ID: 21105469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of urinary albumin and serum high molecular weight-adiponectin with metabolic syndrome in patients with essential hypertension.
    Zhu S; Zhang L; Song H; Liu R; Xu Z; Bo J; Zhang H; Meng QH
    Clin Chem Lab Med; 2012 Nov; 50(11):2045-7. PubMed ID: 23096762
    [No Abstract]   [Full Text] [Related]  

  • 9. The metabolic syndrome as a prohypertensive state.
    Mulé G; Cerasola G
    Am J Hypertens; 2008 Jan; 21(1):8. PubMed ID: 18268791
    [No Abstract]   [Full Text] [Related]  

  • 10. Both the platelet count and the platelet: lymphocyte ratio are not increased in nascent metabolic syndrome.
    Jialal G; Adams-Huet B; Jialal I
    Platelets; 2019; 30(8):1057-1058. PubMed ID: 31373253
    [No Abstract]   [Full Text] [Related]  

  • 11. The morphofunctional features of platelets against the background of metabolic syndrome in patients with generalized marginal periodontitis.
    Vasil'ev YL; Kytko OV; Smetneva NS; Goloborodova IV; Nelipa MV
    Diabetes Metab Syndr; 2019; 13(1):730-733. PubMed ID: 30641796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aggregation function of platelets in persons with arterial hypertension and abdominal obesity].
    Simonenko VB; Medvedev NN; Nosova TIu
    Klin Med (Mosk); 2008; 86(5):22-4. PubMed ID: 18589711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in platelet function in patients with arterial hypertension].
    Malý J; Pecka M; Pintérová E; Pidrman V; Bláha M; Siroký O; Jebavý L
    Vnitr Lek; 1995 Jul; 41(7):458-61. PubMed ID: 7571480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of eprosartan on thrombocytes aggregative capacity in patients with arterial hypertension and metabolic syndrome].
    Simonenko VB; Medvedev IN; Kumova TA
    Klin Med (Mosk); 2008; 86(4):19-21. PubMed ID: 18494280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The link between trace elements and metabolic syndrome/oxidative stress in essential hypertension with or without type 2 diabetes].
    Gouaref I; Bellahsene Z; Zekri S; Alamir B; Koceir EA
    Ann Biol Clin (Paris); 2016; 74(2):233-43. PubMed ID: 27029728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of antihypertensive agents on plasmatic and vascular-thrombocytic homeostasis in metabolic syndrome].
    Vengerovskiĭ AI; Idrisova EM; Bushkova EA; Mananko EI; Krasnova NM
    Eksp Klin Farmakol; 2008; 71(6):8-12. PubMed ID: 19140507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome and the prostate.
    Gilling PJ
    BJU Int; 2018 May; 121(5):675. PubMed ID: 29687952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Normodipin in correction of platelet rheology in hypertensive patients with metabolic syndrome].
    Medvedev IN; Gromnatskiĭ NI
    Ter Arkh; 2005; 77(6):65-8. PubMed ID: 16078604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet production time and spontaneous platelet aggregation in the early stage of arterial hypertension].
    Zawilska K; Komarnicki M; Zozulińska M; Kurnatowska A; Psuja P; Przybył L; Wysocki K
    Pol Arch Med Wewn; 1982 Nov; 68(5):343-50. PubMed ID: 7182835
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aggregation of blood platelets and their energetic status in acute arterial hypertension].
    Shestakova SA; Stepanian ML
    Patol Fiziol Eksp Ter; 1989; (3):61-3. PubMed ID: 2797903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.